Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

Latin America continues to lag the global decline in HIV-related mortality, prompting experts to identify research priorities ...

From delayed diagnoses to unequal pain treatment, racial bias in medicine can shape care in ways clinicians may not even ...

The FDA has approved belzutifan (Welireg, Merck) in combination with pembrolizumab (Keytruda, Merck) or the subcutaneous ...

Intermittent theta-burst stimulation matches the efficacy of standard transcranial magnetic stimulation for depression in ...

Patients place high value on listening, trust, and clear communication, which are factors that shape adherence, satisfaction, ...

Autologous hematopoietic stem cell transplant at experienced centers in the current era can include indefinite disease ...

Prepregnancy insulin resistance is associated with impaired fertility and increased pregnancy complications such as ...

Exosomes emerge as a potential alternative to stem cells in regenerative medicine, and early studies suggest roles in skin ...

The risk for extrahepatic cancers varies among subgroups of steatotic liver disease, with the highest risk seen in patients ...

Higher levels of Fitbit-recorded physical activity are linked to lower odds of irritable bowel syndrome, whereas greater ...

A systematic review and meta-analysis shows that young people not in employment, education, or training face a significantly ...